DHG Pharma ranked 8th in the top 10 best working environments in the Pharmaceutical/Medical Equipment/Healthcare industry and 35th in the "Top 100 best places to work in Vietnam".

From October 07-09, 2022, DHG's Glumeform XR brand accompanied the Vietnam Cardiology Association to organize The 18th National Heart Congress with topic "30 years of Vietnamese Cardiology: Formation - Integration - Development" at Ha Long City. More than 1000 medical professionals who is doctors and pharmacists form hopitals attended the conference, together with 10,000 reaches of digital platforms.

On July 9th of 2022, DHG Pharma officially starts construction of Betalactam factory which meets JAPAN/EU_GMP standards.

The project will be built in Tan Phu Thanh Industrial Zone - Phase 1, Chau Thanh A district, Hau Giang province on a total project area of about 6 hectares with the design including production lines of non-coated tablets; film-coated tablets; hard capsules; powder for oral suspension; granules for oral suspension. It is expected that once completion and operation in 2024, new factory will have nearly twice the design capacity of the current plant.

Expanding products according to international standards to serve Vietnamese people and accelerating the export channel are two main pillars that help Hau Giang Pharmacy become more and more integrated with the advanced level of the global pharmaceutical and health care industry.

From May 17 to 18, the delegation of Can Tho City People's Committee carried out freely medical examination and medicine distribution and gift offering to people in Romeas Haek District, Svay Rieng Province, Kingdom of Cambodia.

For nearly half a century, DHG Pharma has pioneered to bring consumers prestigious and quality products. The brands such as Naturenz, NattoEnzym were born from the scientific research topics of domestic and foreign research institutes, high-quality raw materials imported from the countries with strict standards in the world and modern production technology.

This information was given by the representatives of DHG Pharmaceutical Joint-stock Company at Annual General Meeting of Shareholders 2021 held on March 18th.

Great strides in food supplement market have affirmed DHG Pharma’s heart and vision in accompanying Vietnamese consumers in health care.

Thanks to the improving economic conditions and the intellectual level development, Vietnamese consumers are increasingly interested in disease prevention rather than cure, by adjusting their lifestyles and using more health-promoting foods. Research released in 2021 by Euromonitor assessed that, due to an aging population and higher living standards, Vietnam has become an attractive market for health protection food.